Evaluate Safety and Biological Activity of ATYR1940 in Participants With Early Onset Facioscapulohumeral Muscular Dystrophy
Clinical trial NCT02603562 · COMPLETED
Trial details
- NCT number
- NCT02603562
- Sponsor
- aTyr Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-30
- Primary completion
- 2016-12-12
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.